<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "riociguat tab">
<dose><value>0.5</value>
<value>1</value>
<value>1.5</value>
<value>2</value>
<value>2.5</value>
</dose><route><value>PO</value>
</route><form><value>tab</value>
</form><drugname><value>riociguat tab</value>
</drugname><strength><value>0.5 mg</value>
<value>1 mg</value>
<value>1.5 mg</value>
<value>2 mg</value>
<value>2.5 mg</value>
</strength><frequency><value>TID</value>
</frequency><instruction></instruction><volume></volume><units><value>mg</value>
</units><additionalnotes><value>Increased risk of mortality and serious adverse effects in patients with Pulmonary Hypertension associated with Idiopathic Interstitial Pneumonias. [Health Canada August 15, 2016]</value>
</additionalnotes><population></population><indicationprn></indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=8681</value>
<value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=8682</value>
<value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=8683</value>
<value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=8684</value>
<value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=8685</value>
</backgroundinformation><prninformation></prninformation><ahsformularystatus><value>Formulary with Restrictions.</value>
</ahsformularystatus><ahfsname><value>Vasodilating Agents</value>
</ahfsname><highalert></highalert><maximumprndose></maximumprndose><din><value>02412764</value>
<value>02412772</value>
<value>02412799</value>
<value>02412802</value>
<value>02412810</value>
</din></drug>